Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yan-Ying Qian, Zhi-Juan Dai, Lu-Ya Ruan, You-Jin Pan, Jian Jin, Meng-Te Shi, Yao-Xin Zhu & Chao-Ming Wu. (2019) Low-dose adefovir dipivoxil–induced hypophosphatemia osteomalacia in five chronic hepatitis B virus–infected patients. Is low-dose adefovir dipivoxil–induced nephrotoxicity completely reversible?. Drug Design, Development and Therapy 13, pages 1127-1133.
Read now
Read now
Articles from other publishers (27)
Haichao He & Yong-Jin Zhang. (2023) Multiple-level spinal fractures due to adefovir-induced Fanconi syndrome and hypophosphatemic osteomalacia: A case report. Asian Journal of Surgery 46:4, pages 1712-1713.
Crossref
Crossref
Zhouqi Tang, Tengfang Li, Helong Dai, Chen Feng, Xubiao Xie, Fenghua Peng, Gongbin Lan, Shaojie Yu, Yu Wang, Chunhua Fang, Manhua Nie, Xiaoqiong Yuan, Xiaotian Tang, Xin Jiang, Xuejing Zhu, Yuxi Fan, Jiawei Peng, Siyu Sun, Mingda Zhong, Hedong Zhang & Longkai Peng. (2022) Drug-induced Fanconi syndrome in patients with kidney allograft transplantation. Frontiers in Immunology 13.
Crossref
Crossref
Qian Xiang, Zhiyan Liu, Yanyan Yu, Hanxu Zhang, Qiufen Xie, Guangyan Mu, Jianhua Zhang, Xinan Cen & Yimin Cui. (2020) Osteomalacia and renal failure due to Fanconi syndrome caused by long-term low-dose Adefovir Dipivoxil: a case report. BMC Pharmacology and Toxicology 21:1.
Crossref
Crossref
Kaixin Song, Qi Yan, Yi Yang, Mengyue Lv, Yuting Chen, Yue Dai, Le Zhang, Yi Huang, Cuntai Zhang & Hongyu Gao. (2020) Fanconi syndrome induced by adefovir dipivoxil: a case report and clinical review. Journal of International Medical Research 48:10, pages 030006052095471.
Crossref
Crossref
Takashi Makita, Hirotaka Kanzaki, Hideki Onishi, Ailee Ikeda, Akinobu Takaki, Nozomu Wada, Yasuto Takeuchi, Tetsuya Yasunaka, Fusao Ikeda, Hidenori Shiraha, Yuta Tanaka, Shigeki Nishihara, Kiminaka Murakawa, Yoshihisa Kitamura, Hiroyuki Okada & Toshiaki Sendo. (2019) Adefovir Dipivoxil-induced Fanconi's Syndrome and Osteomalacia Following Multiple Bone Fractures in a Patient with Chronic Hepatitis B. YAKUGAKU ZASSHI 139:4, pages 641-645.
Crossref
Crossref
Mauro Viganò, Alessandro Loglio, Sara Labanca, Serena Zaltron, Francesco Castelli, Pietro Andreone, Vincenzo Messina, Roberto Ganga, Nicola Coppola, Aldo Marrone, Maurizio Russello, Alfredo Marzano, Alessandra Tucci, Gloria Taliani, Massimo Fasano, Stefano Fagiuoli, Erica Villa, Fabrizio Bronte, Teresa Santantonio, Giuseppina Brancaccio, Vincenzo Occhipinti, Floriana Facchetti, Glenda Grossi, Mariagrazia Rumi & Pietro Lampertico. (2019) Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir. Liver International 39:3, pages 484-493.
Crossref
Crossref
I. Carey, R. Byrne, K. Childs, M. Horner, M. Bruce, B. Wang, G. Dusheiko & K. Agarwal. (2018) Serum NGAL can act as an early renal safety biomarker during long-term nucleos(t)ide analogue antiviral therapy in chronic hepatitis B. Journal of Viral Hepatitis 25:10, pages 1139-1150.
Crossref
Crossref
Yao Zhang, Jing Li, Fahong Li, Xun Qi & Jiming Zhang. (2018) Neutrophil gelatinase-associated lipocalin accurately predicts renal tubular injury in patients with chronic hepatitis B treated with nucleos(t)ide analogs. Hepatology Research 48:2, pages 144-152.
Crossref
Crossref
Robert MaweniJrJr, Jins Kallampallil, Szewai Leong & Srikanth Akunuri. (2017) Concomitant AIDS cholangiopathy and Fanconi syndrome as complications of HIV in a single patient. BMJ Case Reports, pages bcr-2017-222333.
Crossref
Crossref
Tatsuo Yamamoto, Yasuhiko Maruyama, Naro Ohashi, Hideo Yasuda & Masami Shinozaki. (2017) Hypophosphatemia predicts a failure to recover from adefovir-related renal injury after dose reduction in lamivudine-resistant hepatitis B patients. Hepatology Research 47:12, pages 1272-1281.
Crossref
Crossref
Fan Pan, Yingchao Wang, Xin Zhang, Qingfeng Lin, Xiaolong Liu, Yi Jiang & Chen Pan. (2017) Long-term adefovir therapy may induce Fanconi syndrome: A report of four cases. Experimental and Therapeutic Medicine.
Crossref
Crossref
Qing Luo, Yong Deng, Feifei Cheng, Juan Kang, Shan Zhong, Dazhi Zhang & Weiqiong Zeng. (2016) Relationship between nephrotoxicity and long-term adefovir dipivoxil therapy for chronic hepatitis B. Medicine 95:50, pages e5578.
Crossref
Crossref
Tomas Laho, John D. Clarke, Anika L. Dzierlenga, Hui Li, David M. Klein, Michael Goedken, Stanislav Micuda & Nathan J. Cherrington. (2016) Effect of nonalcoholic steatohepatitis on renal filtration and secretion of adefovir. Biochemical Pharmacology 115, pages 144-151.
Crossref
Crossref
Yuemin Nan, Shanshan Hong, Xuemin Niu, Wencong Li, Suxian Zhao, Rongqi Wang & Yuguo Zhang. (2016) Telbivudine protects against renal impairment in patients with chronic hepatitis B infection. Future Virology 11:3, pages 219-232.
Crossref
Crossref
Mauro Viganò, Massimo Puoti & Pietro Lampertico. 2016. Hepatitis B Virus in Human Diseases. Hepatitis B Virus in Human Diseases
339
359
.
B.-F. Wang, Y. Wang, B.-Y. Wang, F.-R. Sun, D. Zhang & Y.-S. Chen. (2015) Osteomalacia and Fanconi's syndrome caused by long-term low-dose adefovir dipivoxil. Journal of Clinical Pharmacy and Therapeutics 40:3, pages 345-348.
Crossref
Crossref
Paolo Maggi, Vincenzo Montinaro, Armando Leone, Massimo Fasano, Anna Volpe, Chiara Bellacosa, Vito Grattagliano, Laura Coladonato, Giovanni Lapadula, Teresa Santantonio & Gioacchino Angarano. (2015) Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. Journal of Antimicrobial Chemotherapy 70:4, pages 1150-1154.
Crossref
Crossref
Yuko Shimizu, Atsushi Hiraoka, Hiroka Yamago, Akiko Shiraishi, Yusuke Imai, Haruka Tatsukawa, Tetsuya Tanihira, Hideki Miyata, Tomoyuki Ninomiya, Yoshio Tokumoto, Masanori Abe, Yoichi Hiasa & Kojiro Michitaka. (2014) Hypophosphatemia in patients with hepatitis B virus infection undergoing long-term adefovir dipivoxil therapy. Hepatology Research 44:11, pages 1081-1087.
Crossref
Crossref
A. M. Hall, P. Bass & R. J. Unwin. (2013) Drug-induced renal Fanconi syndrome. QJM 107:4, pages 261-269.
Crossref
Crossref
Hiroyuki Eguchi, Munehisa Tsuruta, Junichi Tani, Reiichiro Kuwahara & Yuji Hiromatsu. (2014) Hypophosphatemic Osteomalacia Due to Drug-induced Fanconi's Syndrome Associated with Adefovir Dipivoxil Treatment for Hepatitis B. Internal Medicine 53:3, pages 233-237.
Crossref
Crossref
Faye Wang & Oliver P. Flint. (2013) BMS-986001, an HIV Nucleoside Reverse Transcriptase Inhibitor, Does Not Degrade Mitochondrial DNA in Long-Term Primary Cultures of Cells Isolated from Human Kidney, Muscle, and Adipose Tissue. Antimicrobial Agents and Chemotherapy 57:12, pages 6205-6212.
Crossref
Crossref
Roland Seifert & Stefan Dove. (2013) Inhibitors of Bacillus anthracis edema factor. Pharmacology & Therapeutics 140:2, pages 200-212.
Crossref
Crossref
Mona Abdel-Hady & Deirdre Kelly. (2013) Chronic Hepatitis B in Children and Adolescents: Epidemiology and Management. Pediatric Drugs 15:4, pages 311-317.
Crossref
Crossref
Wai-Kay Seto, Kevin Liu, James Fung, Danny Ka-Ho Wong, John Chi-Hang Yuen, Ivan Fan-Ngai Hung, Ching-Lung Lai & Man-Fung Yuen. (2012) Outcome of Lamivudine-Resistant Chronic Hepatitis B after up to 5 Years of Combination Therapy with Adefovir. Antiviral Therapy 17:7, pages 1255-1262.
Crossref
Crossref
Massimiliano Paganelli, Xavier Stephenne & Etienne M. Sokal. (2012) Chronic hepatitis B in children and adolescents. Journal of Hepatology 57:4, pages 885-896.
Crossref
Crossref
C. L. Dai, M. Zhu, B. P. Wang, F. Guo, X. Zhang, W. Z. Song, T. H. Zhu, B. L. Wang & M. C. Qiu. (2012) Prolonged adefovir therapy associated Fanconi syndrome and interstitial nephritis in hepatitis B. Internal Medicine Journal 42:8, pages 955-957.
Crossref
Crossref
Roland Seifert & Stefan Dove. (2012) Towards selective inhibitors of adenylyl cyclase toxin from Bordetella pertussis. Trends in Microbiology 20:7, pages 343-351.
Crossref
Crossref